Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy Withdrawal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02471976
What this trial is testing

Impact of an Early Palliative Approach

Who this might be right for
Criteria of Vulnerability
Assistance Publique - Hôpitaux de Paris 1,172
Post-approval studies (Phase 4)Looking for participantsNCT07691138
What this trial is testing

Stopping PPI Therapy in Inactive IBD

Who this might be right for
Ulcerative Colitis (UC)Crohn's Disease
University of Nottingham 80
Not applicableStudy completedNCT04140955
What this trial is testing

Opioid Tapering After Spine Surgery

Who this might be right for
Opioid WithdrawalPostoperative Pain
Aarhus University Hospital 110
Testing effectiveness (Phase 2)Ended earlyNCT04820842
What this trial is testing

TAK-994 in Adults With Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT 1)
Takeda 26
Not applicableStudy completedNCT00006316
What this trial is testing

Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs

Who this might be right for
HIV InfectionsHistoplasmosis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT02675998
What this trial is testing

An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)

Who this might be right for
Hyperphosphatemia
Ardelyx 219
Not applicableUnknownNCT04143087
What this trial is testing

Withdrawal or Reduction TKIs in CML-CP

Who this might be right for
MMR on 12 Month
Nanfang Hospital, Southern Medical University 100
Not applicableUnknownNCT01489384
What this trial is testing

Cimzia Treatment in Rheumatoid Arthritis: Randomizing to Stop Versus Continue Disease-modifying Anti-rheumatic Drug(s)

Who this might be right for
Rheumatoid Arthritis
Pope Research Corporation 125
Large-scale testing (Phase 3)Study completedNCT05980260
What this trial is testing

Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach

Who this might be right for
Neonatal Opiate Withdrawal Syndrome
HELP for NOWS Consortium 626
Post-approval studies (Phase 4)Study completedNCT02200822
What this trial is testing

Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients

Who this might be right for
Heart Failure (HF)
Hasselt University 80
Large-scale testing (Phase 3)Study completedNCT05579327
What this trial is testing

Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)

Who this might be right for
Monocarboxylate Transporter 8 DeficiencyAllan-Herndon-Dudley Syndrome
Rare Thyroid Therapeutics International AB 20
Large-scale testing (Phase 3)Study completedNCT00236392
What this trial is testing

Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)

Who this might be right for
Gastroesophageal RefluxHeartburn
Janssen Pharmaceutica N.V., Belgium 422
Post-approval studies (Phase 4)UnknownNCT05151861
What this trial is testing

Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy:

Who this might be right for
Heart Failure
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 60
Testing effectiveness (Phase 2)UnknownNCT02083874
What this trial is testing

Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study

Who this might be right for
Cannabis Use Disorder
The University of New South Wales 5
Not applicableStudy completedNCT05041023
What this trial is testing

Experience of Relatives and Intensive Care Units Caregivers of Controlled Donation After Circulatory Death

Who this might be right for
Death, AssistedTissue and Organ ProcurementLife Support Care
Assistance Publique - Hôpitaux de Paris 367
Large-scale testing (Phase 3)Study completedNCT03287960
What this trial is testing

Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity

Who this might be right for
Leptin Receptor Deficiency Obesity
Rhythm Pharmaceuticals, Inc. 15
Early research (Phase 1)Study completedNCT01204723
What this trial is testing

Medications Development for the Treatment of Cannabis Related Disorders

Who this might be right for
Nicotine WithdrawalMarijuana DependenceCannabis Dependence+2 more
University of Virginia 63
Post-approval studies (Phase 4)Study completedNCT00704249
What this trial is testing

VENICE Study Nevirapine Full Dose/Dose Escalation

Who this might be right for
HIV Infections
Clinical Trial Agency of HIV Study Group 80
Early research (Phase 1)Study completedNCT01212185
What this trial is testing

Oxytocin Treatment of Alcohol Withdrawal

Who this might be right for
Alcohol Withdrawal
University of North Carolina, Chapel Hill 14
Testing effectiveness (Phase 2)Study completedNCT04034316
What this trial is testing

Reduce Immunosuppression With Atmp in NS ChildrEn

Who this might be right for
Nephrotic Syndrome in ChildrenSteroid-Dependent Nephrotic SyndromeIdiopathic Nephrotic Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 20
Next Page